Strictly Lobar Cerebral Microbleeds Are Associated with Cognitive Impairment

Stroke

Volumn 47, Issue 10, 2016, Pages 2497-2502

  Chung, Chih Ping ^a,f   Chou, Kun Hsien ^c,e   Chen, Wei Ta ^a,b,e,f   Liu, Li Kuo ^a,d,e   Lee, Wei Ju ^a   Chen, Liang Kung ^a,b,d   Lin, Ching Po ^c   Wang, Pei Ning ^a,d,e,f  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b Graduate Institute of Clinical Medical Science School of Medicine   (Taiwan)

^c Institute of Neuroscience   (Taiwan)

^d Aging and Health Research Center   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f Department of Neurology ^*  (Taiwan)

Author keywords

aging; cerebral microbleeds; cognitive function; executive function

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN HEMORRHAGE; COGNITIVE DEFECT; DIFFUSION WEIGHTED IMAGING; EXECUTIVE FUNCTION; FEMALE; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; MINI MENTAL STATE EXAMINATION; PRIORITY JOURNAL; TASK PERFORMANCE; VERBAL COMMUNICATION; VERBAL MEMORY; AGING; BRAIN; COGNITIVE DYSFUNCTION; COMPLICATION; DIAGNOSTIC IMAGING; LONGITUDINAL STUDY; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOLOGY; PSYCHOLOGY; RISK FACTOR;

AGED; AGING; BRAIN; CEREBRAL HEMORRHAGE; COGNITIVE DYSFUNCTION; EXECUTIVE FUNCTION; FEMALE; HUMANS; LANGUAGE; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MEMORY; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; RISK FACTORS;

EID: 84987616083     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.116.014166     Document Type: Article

References (42)

1. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, et al; STandards for ReportIng Vascular changes on nEuroimaging (STRIVE v1). Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822-838. doi: 10.1016/S1474-4422(13)70124-8.
2. Wardlaw JM, Smith C, Dichgans M. Mechanisms of sporadic cerebral small vessel disease: insights from neuroimaging. Lancet Neurol. 2013;12:483-497. doi: 10.1016/S1474-4422(13)70060-7.
3. Poels MM, Vernooij MW, Ikram MA, Hofman A, Krestin GP, van der Lugt A, et al. Prevalence and risk factors of cerebral microbleeds: an update of the Rotterdam scan study. Stroke. 2010;41(10 suppl):S103- S106. doi: 10.1161/STROKEAHA.110.595181.
4. Jeerakathil T, Wolf PA, Beiser A, Hald JK, Au R, Kase CS, et al. Cerebral microbleeds: prevalence and associations with cardiovascular risk factors in the Framingham Study. Stroke. 2004;35:1831-1835. doi: 10.1161/01. STR.0000131809.35202.1b.
5. Sveinbjornsdottir S, Sigurdsson S, Aspelund T, Kjartansson O, Eiriksdottir G, Valtysdottir B, et al. Cerebral microbleeds in the population based AGES-Reykjavik study: prevalence and location. J Neurol Neurosurg Psychiatry. 2008;79:1002-1006. doi: 10.1136/ jnnp.2007.121913.
6. Cordonnier C, van der Flier WM. Brain microbleeds and Alzheimer's disease: innocent observation or key player? Brain. 2011;134(pt 2):335-344. doi: 10.1093/brain/awq321.
7. Ding J, Sigurdsson S, Garcia M, Phillips CL, Eiriksdottir G, Gudnason V, et al. Risk factors associated with incident cerebral microbleeds according to location in older people: the Age, Gene/Environment Susceptibility (AGES)-Reykjavik Study. JAMA Neurol. 2015;72:682-688. doi: 10.1001/jamaneurol.2015.0174.
8. Greenberg SM, Vernooij MW, Cordonnier C, Viswanathan A, Al-Shahi Salman R, Warach S, et al; Microbleed Study Group. Cerebral micro-bleeds: a guide to detection and interpretation. Lancet Neurol. 2009;8:165-174. doi: 10.1016/S1474-4422(09)70013-4.
9. Lee WJ, Liu LK, Peng LN, Lin MH, Chen LK; ILAS Research Group. Comparisons of sarcopenia defned by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study. J Am Med Dir Assoc. 2013;14:528.e1-528.e7. doi: 10.1016/j.jamda.2013.03.019.
10. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
11. Radloff LS. The CES-D Scale: a self-report depression scale for research in the general population. Appl Psychol Meas.1977;1:385-401. doi: 10.1177/014662167700100306.
12. Chang CC, Kramer JH, Lin KN, Chang WN, Wang YL, Huang CW, et al. Validating the Chinese version of the verbal learning test for screening Alzheimer's disease. J Int Neuropsychol Soc. 2010;16:244-251. doi: 10.1017/S1355617709991184.
13. Harrison JE, Buxton P, Husain M, Wise R. Short test of semantic and phonological fuency: normal performance, validity and test-retest reliability. Br J Clin Psychol. 2000;39(pt 2):181-191.
14. Taylor LB. Localisation of cerebral lesions by psychological testing. Clin Neurosurg. 1969;16:269-287.
15. Agrell B, Dehlin O. The clock-drawing test. 1998. Age and ageing.2012;41 Suppl 3:iii41-45.
16. Hester RL, Kinsella GJ, Ong B. Effect of age on forward and backward span tasks. J Int Neuropsychol Soc. 2004;10:475-481. doi: 10.1017/ S1355617704104037.
17. Liu HC, Lin KN, Teng EL, Wang SJ, Fuh JL, Guo NW, et al. Prevalence and subtypes of dementia in Taiwan: a community survey of 5297 individuals. J Am Geriatr Soc. 1995;43:144-149.
18. Sun Y, Lee HJ, Yang SC, Chen TF, Lin KN, Lin CC, et al. A nationwide survey of mild cognitive impairment and dementia, including very mild dementia, in Taiwan. PLoS One. 2014;9:e100303. doi: 10.1371/journal. pone.0100303.
19. Gregoire SM, Chaudhary UJ, Brown MM, Yousry TA, Kallis C, Jäger HR, et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology. 2009;73:1759-1766. doi: 10.1212/WNL.0b013e3181c34a7d.
20. Stark DD, Bradley WG. Magnetic Resonance Imaging. 3rd ed. St Louis: Mosby; 1999.
21. Fazekas F, Chawluk JB, Alavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am J Roentgenol. 1987;149:351-356. doi: 10.2214/ajr.149.2.351.
22. Qiu C, Cotch MF, Sigurdsson S, Jonsson PV, Jonsdottir MK, Sveinbjrnsdottir S, et al. Cerebral microbleeds, retinopathy, and dementia: the AGES-Reykjavik Study. Neurology. 2010;75:2221-2228. doi: 10.1212/WNL.0b013e3182020349.
23. Yakushiji Y, Noguchi T, Hara M, Nishihara M, Eriguchi M, Nanri Y, et al. Distributional impact of brain microbleeds on global cognitive function in adults without neurological disorder. Stroke. 2012;43:1800-1805. doi: 10.1161/STROKEAHA.111.647065.
24. Martinez-Ramirez S, Greenberg SM, Viswanathan A. Cerebral micro-bleeds: overview and implications in cognitive impairment. Alzheimers Res Ther. 2014;6:33. doi: 10.1186/alzrt263.
25. Hilal S, Saini M, Tan CS, Catindig JA, Koay WI, Niessen WJ, et al. Cerebral microbleeds and cognition: the epidemiology of dementia in Singapore study. Alzheimer Dis Assoc Disord. 2014;28:106-112. doi: 10.1097/WAD.0000000000000015.
26. Branco LD, Cotrena C, Pereira N, Kochhann R, Fonseca RP. Verbal and visuospatial executive functions in healthy elderly: the impact of education and frequency of reading and writing. Dement Neuropsychol.2014;8:155-161.
27. Iachini I, Iavarone A, Senese VP, Ruotolo F, Ruggiero G. Visuospatial memory in healthy elderly, AD and MCI: a review. Curr Aging Sci. 2009;2:43-59.
28. Jenkins L, Myerson J, Joerding JA, Hale S. Converging evidence that visuospatial cognition is more age-sensitive than verbal cognition. Psychol Aging. 2000;15:157-175.
29. Poels MM, Ikram MA, van der Lugt A, Hofman A, Niessen WJ, Krestin G P, et al. Cerebral microbleeds are associated with worse cognitive function: the Rotterdam Scan Study. Neurology. 2012;78:326-333. doi: 10.1212/WNL.0b013e3182452928.
30. van Norden AG, van den Berg HA, de Laat KF, Gons RA, van Dijk EJ, de Leeuw FE. Frontal and temporal microbleeds are related to cognitive function: the Radboud University Nijmegen Diffusion Tensor and Magnetic Resonance Cohort (RUN DMC) Study. Stroke. 2011;42:3382-3386. doi: 10.1161/STROKEAHA.111.629634.
31. Dierksen GA, Skehan ME, Khan MA, Jeng J, Nandigam RN, Becker JA, et al. Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann Neurol. 2010;68:545-548. doi: 10.1002/ana.22099.
32. Yates PA, Sirisriro R, Villemagne VL, Farquharson S, Masters CL, Rowe CC; AIBL Research Group. Cerebral microhemorrhage and brain β-amyloid in aging and Alzheimer disease. Neurology. 2011;77:48-54. doi: 10.1212/WNL.0b013e318221ad36.
33. Xu F, Grande AM, Robinson JK, Previti ML, Vasek M, Davis J, et al. Early-onset subicular microvascular amyloid and neuroinfammation correlate with behavioral defcits in vasculotropic mutant amyloid beta-protein precursor transgenic mice. Neuroscience. 2007;146:98-107. doi: 10.1016/j.neuroscience.2007.01.043.
34. Boyle PA, Yu L, Nag S, Leurgans S, Wilson RS, Bennett DA, et al. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology. 2015;85:1930-1936. doi: 10.1212/ WNL.0000000000002175.
35. Enzinger C, Fazekas F, Matthews PM, Ropele S, Schmidt H, Smith S, et al. Risk factors for progression of brain atrophy in aging: six-year follow-up of normal subjects. Neurology. 2005;64:1704-1711. doi: 10.1212/01.WNL.0000161871.83614.BB.
36. Fein G, Di Sclafani V, Tanabe J, Cardenas V, Weiner MW, Jagust WJ, et al. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology. 2000;55:1626-1635.
37. Godin O, Maillard P, Crivello F, Alpérovitch A, Mazoyer B, Tzourio C, et al. Association of white-matter lesions with brain atrophy markers: the three-city Dijon MRI study. Cerebrovasc Dis. 2009;28:177-184. doi: 10.1159/000226117.
38. Schmidt R, Ropele S, Enzinger C, Petrovic K, Smith S, Schmidt H, et al. White matter lesion progression, brain atrophy, and cognitive decline: the Austrian stroke prevention study. Ann Neurol. 2005;58:610-616. doi: 10.1002/ana.20630.
39. Yao M, Jouvent E, During M, Godin O, Hervé D, Guichard J P, et al. Extensive white matter hyperintensities may increase brain volume in cerebral autoso-mal-dominant arteriopathy with subcortical infarcts and leukoencephalopa-thy. Stroke. 2012;43:3252-3257. doi: 10.1161/STROKEAHA.112.664854.
40. Samuraki M, Matsunari I, Yoshita M, Shima K, Noguchi-Shinohara M, Hamaguchi T, et al. Cerebral amyloid angiopathy-related microbleeds correlate with glucose metabolism and brain volume in Alzheimer's disease. J Alzheimers Dis. 2015;48:517-528. doi: 10.3233/JAD-150274.
41. Takashima Y, Mori T, Hashimoto M, Kinukawa N, Uchino A, Yuzuriha T, et al. Clinical correlating factors and cognitive function in community-dwelling healthy subjects with cerebral microbleeds. J Stroke Cerebrovasc Dis. 2011;20:105-110. doi: 10.1016/j.jstrokecerebrovasdis.2009.11.007.
42. Yakushiji Y, Nishiyama M, Yakushiji S, Hirotsu T, Uchino A, Nakajima J, et al. Brain microbleeds and global cognitive function in adults without neurological disorder. Stroke. 2008;39:3323-3328. doi: 10.1161/ STROKEAHA.108.516112.